Examples of 'agalsidase' in a sentence
Meaning of "agalsidase"
Agalsidase is a noun that refers to an enzyme replacement therapy used to treat Fabry disease
Show more definitions
- A form of alpha-galactosidase
How to use "agalsidase" in a sentence
Basic
Advanced
agalsidase
Agalsidase alfa is a highly purified preparation.
There is a theoretical risk of decreased agalsidase alfa activity.
Agalsidase beta may be excreted in milk.
The active substance is agalsidase alfa.
Agalsidase clearance was not influenced by weight in this population.
There is a theoretical risk of decreased agalsidase beta activity.
Agalsidase alfa is a protein and is therefore.
After intravenous administration of agalsidase beta to adults with an infusion time of ca.
Agalsidase alfa is a protein.
Replagal agalsidase alfa.
Replagal is medicine that contains the active substance agalsidase alfa.
Renal elimination of agalsidase beta is considered to be a minor pathway for clearance.
The following adverse reactions have been identified for agalsidase alfa.
Substance agalsidase beta.
Fabrazyme is a medicine that contains the active substance agalsidase beta.
See also
It is not known how agalsidase beta affects pregnant or lactating women.
These changes were associated with the development of low titer antibodies to agalsidase alfa.
Agalsidase beta is a protein and is expected to be metabolically degraded through peptide hydrolysis.
There are no adequate data from the use of agalsidase beta in pregnant women.
The subjects in the agalsidase beta group had higher levels of proteinuria at baseline.
Replagal is a solution for infusion into the body containing the active substance agalsidase alfa.
This study also indicated that agalsidase has no effect on the pharmacokinetics of migalastat.
EPAR summary for the public agalsidase beta.
Agalsidase alfa is a form of the human enzyme α - galactosidase.
Study in patients switching from agalsidase beta to Replagal agalsidase alfa.
Agalsidase alfa is a form of the human enzyme α-galactosidase.
Acute Toxicity Studies The acute toxicity of agalsidase alfa was evaluated in rats.
Agalsidase alfa is unlikely to be a candidate for drug-drug interactions.
There were no effects of agalsidase beta on embryo-fetal development.
Ml of concentrate for solution for infusion contains 1 mg of agalsidase alfa.
As well, clearance of the agalsidase beta was reduced at higher dosages.
Fabrazyme 5 mg powder for concentrate for solution for infusion agalsidase beta.
The reconstituted solution contains 5 mg agalsidase beta per ml, and appears as a clear colourless solution.
Fabrazyme is a solution for infusion ( drip into a vein ) containing the active substance agalsidase beta.
Randomized controlled trials of agalsidase alfa or beta in participants diagnosed with Anderson-Fabry disease.
Each ml of Replagal contains 1 mg of agalsidase alfa.
Following the infusion, agalsidase alfa had a biphasic distribution and elimination profile from the circulation.
Afterwards, all patients were treated with agalsidase beta for six months.
Agalsidase alfa enables the breakdown of Gb3.
Eight patients developed IgG antibodies against agalsidase beta, but they were not neutralizing antibodies.
History of anaphylaxis or Type 1 hypersensitivity reaction to agalsidase beta.
Agalsidase alfa catalyses the hydrolysis of Gb3, cleaving a terminal galactose residue from the molecule.
Fabrazyme 35 mg powder for concentrate for solution for infusion agalsidase beta For intravenous use.
Agalsidase alfa catalyzes the hydrolysis of Gb3, cleaving a terminal galactose residue from the molecule.
One vial of powder contains 35 mg of agalsidase beta.
Pharmacodynamics Agalsidase alfa is a human α-galactosidase A produced in a human cell line by genetic engineering technology.
Each vial of 1 ml of concentrate contains 1 mg of agalsidase alfa.
What is agalsidase beta?
Replagal 1 mg / ml sterile concentrate agalsidase alfa.
Purified agalsidase beta is a homodimeric glycoprotein with a molecular weight of approximately 100 kD.
